sequences, suggesting a key regulatory role for these novel translated 14"
Abstract"
1"
Accurate annotation of protein coding regions is essential for understanding how 2" genetic information is translated into biological functions. Here we describe 3" riboHMM, a new method that uses ribosome footprint data along with gene 4" expression and sequence information to accurately infer translated sequences.
5"
We applied our method to human lymphoblastoid cell lines and identified 7,273 6" previously unannotated coding sequences, including 2,442 translated upstream 7" open reading frames. We observed an enrichment of harringtonine-treated 8" ribosome footprints at the inferred initiation sites, validating many of the novel 9" coding sequences. The novel sequences exhibit significant signatures of 10" selective constraint in the reading frames of the inferred proteins, suggesting that 11" many of these are functional. Nearly 40% of bicistronic transcripts showed 12" significant negative correlation in the levels of translation of their two coding 13"
Introduction

1"
Annotations for coding sequences (CDSs) are fundamental to genomic research. The
2"
GENCODE Consortium (Harrow et al. 2012) has played an important role in annotating 3'UTS-(the first untranslated triplet immediately following the termination site), and 1" 3'UTS (3' Untranslated State). The states {TIS, TIS+, TES, TTS-, TTS} denote translated 2" triplets and {5'UTS, 5'UTS+, 3'UTS-, 3'UTS} denote untranslated triplets. The probability 3" distribution over the possible sequence of latent states is a function of the underlying 4" RNA sequence. Figure 1B illustrates these states, and how they relate to each other, in
5"
conjunction with the transcript representation. The groups of states {5'UTS+, TIS, TIS+}
6"
and {TTS-, TTS, 3'UTS-} help model the distinct structure of the RPF counts around the 7" translation initiation and termination sites, respectively. 
11"
expressed annotated coding transcripts, centered at their translation initiation (blue) and termination
12"
(orange) sites. In aggregate, RPF count data have higher abundance within the CDS than the UTRs and 13" exhibit a 3-base periodicity within the CDS. (B) Each transcript belongs to one of three unobserved reading
14"
frames, and is represented as a sequence of base-triplets (highlighted by differing shades of gray) that 15" depends on the reading frame. Each triplet belongs to one of nine unobserved states. The state sequence
16"
shown corresponds to frame 3 and varying shades from purple to green highlight the different states. Base
17"
positions marked in orange are modeled independently and always belong to the relevant UTS state.
18"
Transitions with nonzero probabilities are indicated by arrows, with solid arrows denoting a probability of 1 19" and dotted arrows denoting probabilities that are a function of the underlying sequence.!
20" 21"
Assuming each transcript has either 0 or 1 CDS, we restricted the possible transitions
22"
between latent states as shown in Figure 1B : transitions from 5'UTS to 5'UTS+ occur
23"
with probability !, transitions from TES to TTS-occur with probability !, and all other 24" allowed transitions have probability 1. The transition probabilities ! and ! are estimated
25"
A. aggregate patterns in footprint data B. model illustration from the data, and are allowed to depend on the base sequence of the triplet; in addition,
1"
the probability ! also depends on the base sequence context around the triplet (Kozak 2" 1987) . In this work, we assume that translation termination occurs at the first in-frame
3"
stop codon (Equation 9), i.e., we do not consider stop codon readthrough.
4"
5"
Conditional on the state assignments, we modeled 1) the total RPF abundance within a 6" triplet, to account for the observation that translated base positions have a higher 7"
average RPF count compared to untranslated base positions, and 2) the distribution of 8"
RPF counts among the base positions in a triplet, to account for the periodicity in RPF 9" counts within translated triplets. We explicitly accounted for differences in RPF
10"
abundance due to differences in transcript expression levels by using transcript-level
11"
RNA-seq data as a normalization factor. The short lengths of ribosome footprints mean 12" that many base positions are unmappable; we treated triplets with unmappable positions
13"
by modifying the emission probabilities accordingly. Finally, we accounted for the
14"
additional variation in RPF counts across triplets assigned to the same state by modeling
15"
overdispersion in the triplet RPF abundance (see Materials and Methods for details).
16"
17"
To quantify the accuracy of our model, we designed a simulation scheme to estimate
18"
what fraction of our inferred translated sequences are false discoveries. We first 19" estimated the Type 1 error rate -i.e., the probability of inferring a translated region when
20"
no such region exists -using a set of simulated transcripts that had no signal of
21"
translation (null transcripts). The simulated transcripts were constructed by permuting
22"
the observed footprint counts in annotated coding transcripts. We then used this
23"
estimate to quantify the false discovery rate for each class of translated CDSs identified 24" by riboHMM. Independently, using a simulated set of transcripts containing some signal
25"
of translation, we quantified the proportion of transcripts where our model incorrectly
26"
identified the precise translation initiation site conditional on having identified a 1" translated sequence (see Materials and Methods for details on the simulations).
2"
3"
Results
4"
Application to human lymphoblastoid cell lines 5"
We applied riboHMM to infer translated CDSs in human lymphoblastoid cell lines (LCLs) 6"
for which gene expression phenotypes were measured genome-wide: mRNA in 86 7" individuals, ribosome occupancy in 72 individuals and protein levels in 60 individuals 8" (Lappalainen et al. 2013; Battle et al. 2015) . We first assembled over 2.8 billion RNA
9"
sequencing reads into transcripts using StringTie (Pertea et al. 2015) . This assembly
10"
gives us annotated transcripts that are expressed in LCLs, along with novel transcripts
11"
that do not overlap any GENCODE annotated gene. (We do not consider novel isoforms
12"
of annotated genes in our analyses.) Restricting to transcripts with at least five footprints 13" mapped to each exon, we used riboHMM to identify high-confidence translated CDS. We
14"
learned the maximum likelihood estimates of the model parameters using the top five
15"
thousand highly expressed genes. The estimated parameters are robust to the choice of
16"
the learning set (Figures S1 and S2). Using these parameters, we then inferred the 17" maximum a posteriori (MAP) frame and latent state sequence for each of the assembled
18"
transcripts. We retained transcripts whose MAP frame and state sequence
19"
corresponded to a pair of translation initiation and termination sites and had a joint 20" posterior probability greater than 0.8. Using a set of simulated null transcripts, we
21"
estimated that this posterior cutoff corresponded to a Type 1 error rate of 4.5% per
22"
transcript. The MAP frame and state sequence directly give us the nucleotide sequence
23"
with the strongest signal of translation; we refer to these as main coding sequences or
24"
mCDS."
25"
Detection of novel CDSs in LCLs 1"
Among 7,801 GENCODE annotated coding genes for which we could infer a high
2"
posterior mCDS, we recovered the annotated reading frame for at least one isoform in 3" 7,491 genes (96%); of these, we recovered the exact annotated CDS in 4,500 genes. In
4"
310 genes, we inferred mCDS that were entirely distinct from the annotated CDS.
5"
( Figure S3 details the rules that decide how our inference agrees with GENCODE.)
6"
Thus, for a subset of GENCODE coding genes, our method identified an mCDS distinct 7" from the annotation. Using simulations, we estimated that riboHMM inaccurately detects 8" a completely novel mCDS at a fairly low rate (Type 1 error rate = 4.5%), but has a higher 9" error rate when identifying the precise translation initiation site (false discovery 10" proportion = 38%; see Materials and Methods for details). Thus, it is likely that many of
11"
the mCDS that have a distinct reading frame compared to annotation are novel alternate 12" translated sequences; however, for those mCDS that only matched the annotated
13"
reading frame, the inferred start sites were false discoveries. Our analysis is also robust
14"
to sequencing depth; Figure S4 illustrates that nearly 60% of annotated coding
15"
sequences identified with the full data set (580 million footprints) could be accurately
16"
recovered even when the sequencing depth was reduced by almost two orders of 17" magnitude.
18"
19"
We identified 4,831 novel mCDS in transcripts expressed in LCLs (FDR = 5.5%). To
20"
ensure that these are truly novel, we verified that they do not overlap any known CDS
21"
annotated by GENCODE, UCSC (Rosenbloom et al. 2015) , or CCDS (Farrell et al.
22"
2014) in the same frame. (See Figure 2 for the different classes of LCL transcripts that 23" contain a novel mCDS; Figure S5 illustrates the decision rules used to identify a novel 24" mCDS). Among these, 814 novel mCDS were identified within GENCODE annotated
25"
protein-coding transcripts; in these transcripts, the mCDS encodes for a protein distinct
26"
from that annotated by GENCODE. Of these, 386 mCDS overlap an annotated CDS but
1"
have a different reading frame (labeled 'dual-coding') and 156 do not overlap the 2" annotated CDS. An example of a novel dual-coding region -an mRNA sequence that 3" codes for proteins in two different frames -inferred in the POLR2M gene is illustrated in 4" Figure 3A . Using tandem mass-spectrometry data (Battle et al. 2015) , we found four
5"
unique spectra matching peptides in the mCDS and no spectra matching peptides in the 6" annotated CDS (protein level posterior error probability = 3×10 !!" ). 
10"
read/footprint depth, or number of transcripts) at each step and the numbers and classes of transcript within
11"
which novel translated sequences were identified. Transcripts assembled by StringTie that do not overlap
12"
any annotated gene are called "novel transcripts". Long non-coding RNA includes lincRNAs, antisense
13"
transcripts and transcripts with retained introns, short non-coding RNA includes snRNA, snoRNA and
14"
miRNA, processed transcripts are transcripts without a long, canonical ORF, and pseudogenes include all
15"
subclasses of such genes annotated by GENCODE. "
16" 17"
In addition, we identified 2,550 mCDS in annotated non-coding transcripts and 1,019 pseudogenes. An mCDS in pseudogene GAPDHP72 is shown in Figure S6A , comparing
5"
the ribosome abundance and peptide matches to the pseudogene mCDS with those of 6"
its parent gene GAPDH.
7"
8" " 9" 
14"
the novel mCDS (gray) compared with the lengths of GENCODE annotated CDSs (black)."
15" 16"
Unlike annotated CDS, which almost exclusively start at the methionine codon AUG,
17"
these novel mCDS taken together have a substantially higher usage of non-canonical
18"
codons, particularly CUG ( Figure 3B 
20"
2012). Although riboHMM has a high error rate when identifying translation initiation 21" sites, our use of a hierarchical model for the initiation sites suggests that the errors in our 1" inferred start codons are likely to be unbiased. These novel mCDS are also significantly 2"
shorter than annotated CDSs (median lengths 23 vs. 339 amino acids, Mann-Whitney
3"
test p-value!<!2.2×10 -16 ; Figure 3C ). The overall amino acid content within novel mCDS
4"
is comparable to that within annotated CDS, with a slight enrichment for arginine,
5"
alanine, cysteine, glycine, proline, and tryptophan residues (binomial test,
6"
p-value!<!1.1×10 -16 ; Figure S7 ).
7"
8"
Below, using an alternative measure of ribosome occupancy, we first assess
9"
independent evidence for translation initiation at many of these novel mCDS. Then, we
10"
test whether these mCDS are functional both using human polymorphism data and using
11"
substitution patterns across vertebrates. Finally, we characterize those mCDS whose
12"
peptide products were identified in mass-spectrometry data.
13"
14"
Translation at novel mCDS validated using harringtonine-treated ribosome 15" footprints 16"
We next sought to provide independent experimental validation for the novel mCDS. A
17"
direct approach to validate translation initiation sites is to assay ribosome occupancy in 18" 
21"
data therefore show a specific enrichment pattern at the translation initiation site; this
22"
pattern has previously been used to identify translation initiation sites in mouse 23" embryonic stem cells (Ingolia et al. 2011 ). We measured harringtonine-treated ribosome
24"
footprints in two LCLs and aggregated the counts of footprints across all novel mCDS.
25"
We observed an enrichment of footprints at the inferred initiation site of the novel mCDS
1"
(binomial test, p-value = 9.5×10 -79 ; Figure 4 ), similar to the enrichment of aggregate 2" ribosome occupancy at the initiation sites of a matched number of mCDS that agreed
3"
exactly with the annotated CDS (see Figure S6B for mCDS in pseudogenes). We
4"
observed a significant enrichment at both AUG p-value = 5.2×10 -79 and non-AUG
5"
p-value = 9.4×10 -25 initiation sites. The reduced enrichment for the novel mCDS
6"
compared to annotated CDSs is likely due to the lower levels of translation of these 7"
novel mCDS and the high error rate in identifying the precise base at which translation is
8"
initiated. Accounting for these limitations, our observation of enrichment suggests that
9"
ribosomes do initiate the translation of many of the novel mCDS identified by riboHMM.
10"
11" " 12" 
13"
Harringtonine-treated ribosome footprints show enrichment at the inferred translation initiation sites, when
14"
aggregated across novel mCDS (orange), similar to the enrichment at the initiation sites of a matched
15"
number of mCDS that agreed exactly with the annotated CDS (purple), suggesting that ribosomes do initiate
16"
translation of the novel mCDS.! !
17"
Selective constraint on coding function in novel mCDS 1"
We next ascertained the functional importance of these novel mCDS based on the 2" selective constraint imposed on random mutations that occur within them. A bi-allelic 3" single nucleotide polymorphism (SNP) that falls within an mCDS can be inferred as
4"
synonymous or nonsynonymous depending on whether switching between the two
5"
alleles of the SNP changes the amino acid sequence of the mCDS. If the mCDS do not
6"
produce proteins that are functionally important, we expect the two classes of variants to
7"
have similar selection pressures on average, and thus to segregate at similar
8"
frequencies. Only if the novel mCDS produce functionally important peptides do we 9" expect inferred nonsynonymous SNPs to segregate at lower frequencies than inferred 10" synonymous SNPs."
11"
12" " 13" 
18"
inferred nonsynonymous variants for each novel mCDS, computed using multiple sequence alignments
19"
across 100 vertebrate species. Highlighted in red are 232 novel mCDS identified to be under significant 20" long-term purifying selection after Bonferroni correction (testing for !" !" < !; p-value < !. !"×!" !! ),
21"
indicating conserved coding function for these sequences.!
22"
Starting with biallelic SNPs identified using whole genome sequences of 2,504 1" individuals (1000 Genomes Project Consortium et al. 2015), we examined the set of
2"
SNPs falling within all novel mCDS (13,907 variants within 3,096 novel mCDS). We
3"
labeled each SNP as synonymous or nonsynonymous with respect to the inferred CDS
4"
and show the cumulative distribution of minor allele frequencies (MAF) of each SNP
5"
class ( Figure 5A ). We observed that nonsynonymous SNPs have an excess of rare
6"
variants compared with synonymous SNPs (Mann-Whitney test; p-value = 1.08×10 !! ),
7"
implying a difference in the intensity of purifying selection (Nielsen 2005) . This observed 8" excess suggests that the novel mCDS are under significant constraint, consistent with 9" functional peptides, albeit weaker than at annotated CDS. The mCDS identified within 10" pseudogenes alone also showed a similar excess of rare variants among
11"
nonsynonymous SNPs (Mann-Whitney test; p-value = 5.6×10 !! ). Such an excess was
12"
not observed for pseudogenes that had detectable ribosome occupancy but lacked a
13"
high-confidence inferred coding sequence ( Figure S6C ); for these pseudogenes, the
14"
SNPs were labeled based on the reading frame of the parent gene. This highlights that
15"
ribosome occupancy alone is insufficient to identify translated sequences, and our
16"
method is able to leverage finer scale structure in ribosome footprint data to detect 17" functional coding sequences.
18"
19"
While the allele frequency spectra provide evidence that some of the novel mCDS are 20" functional in present-day human populations, they are less informative about the long-
21"
term selective constraint on these sequences. To identify whether the novel mCDS have
22"
been under long-term functional constraint, we compared the substitution rates at 23" synonymous and nonsynonymous sites within the novel mCDS using whole-genome
24"
multiple sequence alignments across 100 vertebrates. (We excluded mCDS identified in
25"
pseudogenes from this analysis due to difficulties in assigning orthology.) In Figure 5B ,
1"
232 novel mCDS have a significantly lower nonsynonymous substitution rate (!")
2"
compared to their synonymous substitution rate (!") after Bonferroni correction
3"
(p-value < 2.91×10 !! ) , suggesting that these mCDS have been under long-term 4" purifying selection. Since the power to detect significantly low values of !" !" depends
5"
on the length of the CDS and the qualities of the genome assemblies and the multiple 6" sequence alignments across distant species at these sequences, the number of 7" functional novel CDSs identified is a conservative lower bound." 8"
9"
Detection of novel proteins by mass spectrometry" 10"
We next tested whether we could detect the novel mCDS predictions using mass 11" spectrometry data. We used a large data set of SILAC-labeled tandem mass-spectra 12" generated by trypsin-cleavage of large, stable proteins in many of the same LCLs (Battle 
14"
of 4,831 novel mCDS, at 10% FDR, we identified 161 novel mCDS sequences that have
15"
at least one unique peptide hit --a tryptic peptide that matches a mass-spectrum (Table   16 " S1). More than 70% of novel mCDS with a peptide hit have at least 2 distinct peptides 17" matched to it and, in almost all cases, the unique peptides were independently identified
18"
in two or more LCLs ( Figure S8 ).
19" "
20"
To assess how many hits we would expect to the novel mCDS if their properties were
21"
like those of annotated CDSs, we developed a model that predicts whether an annotated
22"
protein has at least one mass-spectrum match, using features based on expression and
23"
sequence composition of the protein (see Materials and Methods for more details). The
24"
mass-spectrometry data are highly biased towards detection of larger and more highly 25" expressed proteins. Furthermore, the trypsin cleavage step of the experimental protocol 1" imposes strong constraints on the set of unique peptide sequences that can be observed
2"
in an experiment. Assuming that the distributions of these predictive features estimated
3"
from annotated CDSs can be applied to the novel mCDS, we computed the expected 4" number of novel mCDS with a peptide hit to be 603.
5"
6"
We thus find many fewer mass spectrometry hits to the novel mCDS than expected from 7" a model calibrated on previously annotated mCDS (161 vs. 603). The Harringtonine
8"
data argue that many of the novel mCDS are correct predictions, thus we suggest that 9" some other property of the mCDS may explain their low detection rate. In particular, it is
10"
possible that the novel proteins may have higher turnover rates than annotated proteins.
11"
For example it is possible that the proteins translated from novel mCDS may have
12"
substantially lower half-life than annotated proteins, or may be secreted, and thus have 13" too low concentrations within the cell to be detectable by mass spectrometry assays.
14"
" 15"
Translation of short alternate coding sequences in addition to the mCDS 16"
Protein-coding transcripts in eukaryotes are typically annotated to have only one CDS 17" (i.e., they are monocistronic). However, a number of studies have demonstrated that 
21"
2013). Furthermore, anecdotal evidence has suggested that translation of the alternate
22"
CDS serves as a mechanism to suppress translation of the main CDS (Lee et al. 2002;  23" Hernández-Sánchez et al. 2003; Lammich et al. 2004 ). However, assessing such a
24"
mechanism genome-wide has been challenging, mainly due to a lack of appropriate 25"
annotations (Calvo et al. 2009 ).
26"
To this end, we adapted our approach to identify additional coding sequences within 1" transcripts that are translated in LCLs. Assuming that the sub-codon structure of 2" footprint abundance is similar between the main and alternate CDS, we identified 2,442
3"
novel CDSs upstream of the mCDS inferred by our method (FDR!="5%); we call them
4"
upstream alternate coding sequences or uaCDS (see Materials and Methods for more
5"
details; see also Figure S9 ). Figure 6A illustrates the ribosome footprint density within 6" the uaCDS of the transmembrane gene TM7SF2, and its conservation across mammals.
7"
We find strong enrichment of harringtonine-treated ribosome footprints at the initiation 8" sites of uaCDS similar to the initiation sites of mCDS in the same transcripts ( Figure 6B ).
9"
Using mass-spectrometry data, we identified 46 uaCDS that have at least one peptide 10" hit, substantially lower than the expectation of 891 hits predicted by our model. Finally,
11"
comparing the substitution rates at inferred synonymous and nonsynonymous sites, we
12"
identified over 317 uaCDS with highly constrained coding function ( Figure 6C ).
13"
" 15" 
4"
Using multiple sequence alignment across 100 vertebrate species, 317 uaCDS were identified to have 5" strong, significant long-term conservation.
6" 7"
Translation of uaCDS negatively correlates with translation of mCDS 8"
With 2,442 uaCDS identified as translated in LCLs, we next tested the hypothesis that 9" uaCDS expression negatively correlates with mCDS for each pair. We observed that, at 10" 10% FDR, 917 pairs of uaCDS and mCDS had significant negative correlations across
11"
individuals between the proportion of footprints assigned to them ( Figure 7A ). Our
12"
observation that nearly 40% of pairs of uaCDS and mCDS are significantly anti-
13"
correlated, despite incomplete power due to low sample size, suggests that a key role of
14"
alternate CDSs in a transcript is to regulate the translation of the main CDS. 
22"
the mCDS or uaCDS of a transcript is translated) were identified at 10% FDR (41 pairs of mCDS/uaCDS).
23"
(C) Illustrating an example of an orfQTL in the histocompatibility minor serpin domain-containing (HMSD)
24"
gene (introns removed for better visualization). The most significant variant (marked x) lies within an intron
25"
between the mCDS and uaCDS of the transcript.
26" 27"
Variation in ORF usage can be driven by a number of factors including cis genetic 1" effects and trans effects like variation in expression of RNA binding proteins. To identify 2" cis variants that affect ORF usage in a bicistronic transcript, we tested for association of 3" the proportion of RPFs assigned to the mCDS (or uaCDS) with variants in a 10-kilobase 4" window around the transcript; this phenotype effectively controls for variation in gene 5" expression across the LCLs. We identified 365 cis orfQTLs (genetic variants associated
6"
with ORF usage) across 41 pairs of mCDS and uaCDS at 10% FDR ( Figure 7B ). In
7"
Figure 7C, we illustrate an example of an orfQTL in a bicistronic transcript of the HMSD
8"
gene (histocompatibility minor serpin domain-containing); this gene is also known to
9"
have a distinct genetic variant associated with alternative usage of two coding isoforms 10" (Kawase et al. 2007 ). Our observation of orfQTLs in a number of genes distinguishes
11"
ORF usage as an additional layer of post-transcriptional regulation of protein expression.
12"
13"
Discussion
14"
We developed riboHMM, a mixture of hidden Markov models to accurately resolve the
15"
precise set of mRNA sequences that are being translated in a given cell type, using
16"
sequenced RPFs from a ribosome profiling assay, sequenced reads from an RNA-seq 17" assay and the RNA sequence. When applied to human LCLs, this method was able to
18"
accurately identify the translated frame in 96% of annotated coding genes that had a
19"
high posterior mCDS. In addition, a key advantage of our framework is the ability to infer 20" novel translated sequences that may be missed by annotation pipelines that focus on
21"
long CDSs (>100 amino acids), conservation based approaches that require long-term
22"
purifying selection, or direct proteomics measurements that are biased toward highly
23"
expressed, stable proteins. We used riboHMM to identify 7,273 novel CDSs, including
24"
448 of novel translated sequences in pseudogenes and 2,442 bicistronic transcripts that
25"
contain an upstream CDS in addition to a main CDS. We observed enrichment in
1"
harringtonine-arrested ribosome occupancy at the inferred translation initiation sites,
2"
suggesting that many of the novel mCDS are real. These novel sequences showed 3" significant differences in the amount of purifying selection acting on inferred 4" nonsynonymous versus synonymous sites, suggesting that many of these sequences
5"
are conserved as functional peptides, including those mCDS identified in lncRNAs,
6"
pseudogenes and novel transcripts.
7"
8"
One caveat of our model is its restriction on one CDS per transcript. In this study, we 9" worked around this limitation using a greedy approach and identified thousands of
10"
transcripts with multiple CDSs (either two non-overlapping inferred CDSs or an inferred
11"
mCDS distinct from the annotated CDS). Indeed, in some instances where the frame of
12"
the mCDS and annotated CDS of a transcript disagreed, we found strong support from 13" mass-spec data for the inferred mCDS frame ( Figure 3A ). These observations highlight
14"
the existence of a large number of transcripts in humans that have multiple CDSs and
15"
the variation in alternative usage of CDSs across tissues, an area that has largely been
16"
overlooked. Additionally, riboHMM does not effectively distinguish footprints arising from 17" different isoforms and, thus, cannot resolve overlapping translated sequences from 18" multiple coding isoforms of a gene. Extending riboHMM to model multiple, possibly
19"
overlapping CDSs jointly across multiple isoforms could help uncover this additional 20" layer of complexity in the human genome.
21"
22"
While the precise function of these novel CDSs remains unclear, we found evidence 
2"
3"
Our method provides an alternative framework for annotating the coding elements of the
4"
genome. Compared to current methods that use sequence information in cDNA and
5"
protein databases and those that rely on high-quality genome annotations in closely 6" related species, riboHMM provides a relatively unbiased CDS annotation and
7"
opportunities for finding entirely novel CDSs. In particular, one could use riboHMM to 8" identify the set of CDS for a species within a poorly annotated evolutionary clade, using 9" ribosome profiling and RNA seq data immediately after its genome is sequenced and
10"
assembled. In addition, given ribosome footprint profiling data from multiple cell types,
11"
riboHMM can be used to investigate cell-type-specific translation of coding elements
12"
beyond cell-type-specific gene or isoform expression. These features render this tool
13"
particularly useful in studying molecular evolution of newly arisen coding genes and
14"
linking tissue-specificity of CDS usage to disease.
15"
Materials and Methods"
Assembling expressed transcripts in LCLs 2"
We mapped paired-end 75bp RNA-seq reads pooled across 85 Yoruba lymphoblastoid 3" cell lines (Lappalainen et al. 2013) to the Genome Reference Consortium Human
4"
Reference 37 (GRCh37) GENCODE v.19 transcript models to guide the assembly. In addition, we required that 9" the lowest expressed isoform of a gene have no less than 1% the expression of the
10"
highest expressed isoform (-f 0.01), and that each exon-exon junction be supported by
11"
at least 2 spliced reads (-j 2). Since the RNA-seq protocol did not produce strand-
12"
specific reads, we treated the forward strand and reverse strand of a transcript model
13"
assembled by StringTie as distinct transcripts. Our final set of 430,754 expressed
14"
transcripts included 122,168 GENCODE annotated transcript isoforms and 308,586 15" novel isoforms. (We did not consider novel isoforms of annotated genes identified by
16"
StringTie.)
17" 18"
Ribosome footprint profiling" 19"
Ribosome footprint profiling experiments and sequencing data processing were 20" performed as previously described (Battle et al, 2015) , with the exception of a
21"
harringtonine treatment step to arrest ribosomes at the sites of translation initiation.
22"
Briefly, lymphoblastoid cell lines, GM19204 and GM19238, were cultured at 37°C with 23" 5% CO 2 in RPMI media with 15% FBS. The media were further supplemented with 2 mM 24" L-glutamate, 100 IU/ml penicillin, and 100 µg/ml streptomycin. Right before cell lysate
25"
preparation, each culture was treated with 2 µg/ml harringtonine (final concentration in 26" media) for 2 minutes followed by 100 µg/ml cycloheximide (final concentration in media).
27"
For ribosome profiling experiments, ARTseq TM Ribosome Profiling kit for mammalian 28" cells (RPHMR12126) was used following vendor's instructions. Sephacryl S400 spin
29"
columns (GE; 27-5140-01) were used for monosome isolation. Libraries were
30"
sequenced on an Illumina HiSeq 2500. For sequencing data processing and mapping,
31"
adaptor sequences were removed from the 3' end of each read using the Clipper tool
32"
from the FASTX-Toolkit. In addition, the 5' most nucleotide (commonly resulted from
33"
non-templated additions) was removed using the Trimmer tool from the FASTX-Toolkit.
34"
To increase mapping efficiency, we filtered out sequence reads that mapped to rRNA,
35"
tRNA or snoRNA (FASTA files downloaded from Ensembl on 05/02/13) using Bowtie 2, 
39"
Mixture of HMMs to model translated coding sequences 1 Consider N transcripts where the n th transcript has length of L n assumed to be a multiple 2 of three (L n = 3M n ; see Transcripts with length not a multiple of three for details on 3 how our model handles the remaining one or two base positions when L n is not a multiple 4 of three). Our data consist of RPF counts T = (T n ) N n=1 , RNA sequence S = (S n ) N n=1 , and 5 transcript expression E = (E n ) N n=1 (in units of RNA-seq reads per base position per million 6 sequenced reads) on N transcripts, where T n and S n are vector quantities and E n is a 7 scalar aggregated over the entire length of the transcript. Let T n = (T n 1 , . . . , T n Ln ) and S n = 8 (S n 1 , . . . , S n Ln ), where T n b and S n b denote the RPF counts and the base at the b th position 9 in the n th transcript, respectively. We model the footprint data T using a mixture of HMMs 10 that incorporates S and E. Assuming independence across transcripts, the probability of 11 T given S and E is written as P(T |⇥, S, E) = Q N n=1 P(T n |⇥, S n , E n ), where ⇥ denotes the 12 set of model parameters.
13
Mixture of three reading frames for a transcript: To capture the three-base struc-14 ture in RPF data within the CDS, we represent each transcript as a sequence of non-15 overlapping base triplets, some of which potentially represent codons. Since the CDS 16 of the transcript could belong to one of three reading frames (as illustrated in Figure   17 1B), we introduced a latent frame variable, F n 2 {1, 2, 3}, that specifies the reading 18 frame for the n th transcript. Then, given F n = f , T n can be represented as a se-19 quence of M n 1 triplets and three remaining base positions (see Figure 1B ). Specifically, 20 T n | F n = f := (X n f,1 , . . . , X n f,(Mn 1) , R n f ), where X n f,m = (T n 3m 3+f , T n 3m 2+f , T n 3m 1+f ) 
(1)
The probability of T n is then given by
=
We assumed that the probability over F n is independent of S n and E n , and is uniform over 2 all three frames, P(F n = f |S n , E n , ⇥) = 1 3 . In addition, we assumed that the RPF data 3 from the sequence of triplets and the RPF data from the three remaining base positions 4 are independent, leading to 5 P(X n f,1 , . . . , X n f,(Mn 1) , R n f |F n = f ) = P(X n f,1 , . . . , X n f,(Mn 1) |F n = f )P(R n f |F n = f ). (4) (For notation convenience, we have dropped highlighting the dependence of X n and R n 6 on ⇥, S n , and E n .) We modeled the probability of the data from the sequence of triplets, 7 P(X n f,1 , . . . , X n f,(Mn 1) |F n = f ), using an HMM, and the probability of the data from the 8 remaining positions, P(R n f |F n = f ), using a Poisson-gamma model as described below. 9 HMM for each frame of a transcript: The pattern of RPF count data in triplets depends 10 on whether the triplet is being translated or not. To model these patterns, we assumed that 11 each triplet belongs to one of nine states (see Figure 1B) : footprint data around the translation initiation and termination sites, respectively. We intro-21 duced a sequence of M n 1 hidden variables Z n f = (Z n f,1 , . . . , Z n f,(Mn 1) ) for each frame of 22 the n th transcript, where Z n f,m denotes the state for the m th triplet in the f th frame.
For each state, an emission probability for X n f,m can be modeled as follows. Let Y n f,m 24 denote the sum of three elements in X n f,m (i.e., the total RPF count for the m th triplet).
Then, P(X n f,m |Z n f,m = z) = P(X n f,m |Y n f,m , Z n f,m = z)P(Y n f,m |Z n f,m = z) and
where the density of the gamma distribution is P(µ) = ↵ (↵ ) µ ↵ 1 exp µ with the mean 2 and variance equal to ↵ and ↵ , respectively. 3 The periodicity of RPF counts within the CDS is captured by the multinomial distribu-
{5 0 UTS, 5 0 UTS+, 3 0 UTS, 3 0 UTS-} to capture the lack of periodicity in the RPF data in un-6 translated regions. Furthermore, we allow the pattern of periodicity to differ across five 7 types of codons (TIS, TIS+, TTS, TTS-, TES). 8 The Poisson distribution for Y n f,m captures the difference in RPF abundance between trans-9 lated and untranslated regions (precisely, difference in abundance between triplets in dif-10 ferent states). We corrected for differences in RPF abundance across transcripts due to 11 differences in transcript expression levels by using E n as a transcript-specific normaliza-12 tion factor (see Figure S10 ). To account for additional variation in the RPF counts across 13 triplets in the same state (e.g., due to varying translation rates across transcripts, and 14 translational pausing), we allowed for triplet-specific parameters µ n zf m in the Poisson inten-15 sity and assumed that those parameters follow a gamma distribution. Under this model,
We assumed that the sequence of hidden variables Z n f follow a Markov chain. The as- Model for R n f : We model R n f , the RPF counts at bases before or after the sequence 13 of triplets (see Equation (1) ), using the emission probabilities of the 5 0 UTS or 3 0 UTS 14 states. Assuming that the three elements of R n f are independent, we have P
where z = 5 0 UTS if R n f,i 2 {T n 1 , T n 2 }, and z = 3 0 UTS if R n f,i 2 {T n Ln 2 , T n Ln 1 , T n Ln }.
Parameter estimation and inference:
We used an EM algorithm to compute the maxi-18 mum likelihood estimate for the model parameters ⇥ = {⇡ z , ↵ z , z ,  , c }, that is,⇥ := 19 argmax ⇥ P(T |⇥, S, E).
20
To infer the translated CDS for the n th transcript, we identified the frame and state se-21 quence that maximizes the joint posterior probability
We first computed the maximum a posteriori (MAP) state sequence for each reading frame 23 using the Viterbi algorithm, z n ⇤ f := argmax z P(Z n f = z|F n = f, T n , S n , E n ,⇥) for f = 1, 2, 3.
24
Then, the MAP state sequence and frame is given as
where z n ⇤ f is a function of f , P(F n = f |T n , S n , E n ,⇥) / P(T n |F n = f, S n , E n ,⇥)P(F n = 1 f ) and P(T n |F n = f, S n , E n ,⇥) is the probability of the data marginalized over the latent 2 states. 3 In our analyses, we estimated the model parameters using the top five thousand highly 4 expressed genes. Then, we inferred the translated CDS for those transcripts in which 5 each exon has at least five distinct ribosome footprints mapping to it. We restricted our 6 further analyses to transcripts where (1) P(Z n f = z n ⇤ , F n = f n ⇤ |T n , S n , E n ,⇥) > 0.8, (2) 7 the MAP state sequence z n ⇤ contains a TIS state and a TTS state (i.e., a pair of initiation 8 and termination sites), (3) more than 50% of base positions within the inferred CDS are 9 mappable, and (4) the coding sequence encodes a peptide more than 6 amino acids long 10 -we call these translated sequences as main coding sequences or mCDS.
11
Modeling ribosome footprints of different lengths: We observed that ribosome foot-12 prints with different lengths, arising due to incomplete nuclease digestion, show slightly 13 different patterns of abundance when aggregated across transcripts (see Figure S11 ). To 14 model these differences, we partition the footprints into multiple groups based on length, 15 and model the data in each group with a separate set of parameters in the emission prob-16 ability (all groups share the same state sequence along a transcript). Specifically, for G 17 groups of footprints, the data at the m th triplet in f th reading frame X n f,m can be partitioned 18 into G components, X n f,m = (X n g,f m ) G g=1 , where X n g,f m denotes the triplet of RPF counts 19 from g th group. Assuming that the RPF counts from different groups at a given triplet are 20 independent, conditional on the state of the triplet, the emission probability can be written 21 as P(X n f,m |Z n f,m = z) = Q G g=1 P(X n g,f m |Z n f,m = z) and
where group-specific parameters, (⇡ g,z , ↵ g,z , g,z ), capture the distinct patterns in each 23 group. The RPF data used in our analyses had four groups of footprints of lengths 28, 29, the m th base triplet in frame f in the n th transcript. If J n g,f m is the set of positions in this 1 triplet that are unmappable for footprints corresponding to group g, the emission probabili-2 ties become
Y n g,f m |Z n f,m = z ⇠ Poisson( n g,zf m µ n g,zf m E n ),
If all three positions in a triplet are unmappable, then we treat the triplet as having missing 5 data for that footprint group and set P(X n g,f m |Z n f,m ) = 1 for all values of Z n f,m . For the m th triplet in frame f in the n th transcript, using the base sequence from the -9 13 to +6 positions flanking this triplet, we computed K n f,m , the log of ratio of likelihood of the 14 flanking sequence under the Kozak model to likelihood under the background model.
15
Transcripts with length not a multiple of three: The length of such a transcript can be 16 written as L n = 3M n + B, where B 2 {1, 2}. We assumed that the RPF data on the first 17 3M n bases (T n 1:3Mn ) and the data on the remaining B bases (T n 3Mn+1:Ln ) are independent. 18 We modeled T n 1:3Mn using a mixture of HMMs as described above, and modeled T n 3Mn+1:Ln using the emission probability of the 3 0 UTS state as follows.
where z = 3 0 UTS.
2 Quantifying false discoveries of riboHMM 3 We characterize the performance of riboHMM by addressing two scenarios: (1) How often 4 does riboHMM identify an mCDS in transcripts with no signal of translation? (2) How often 5 does riboHMM identify an incorrect initiation site in transcripts with signal for translation? 6 To address the first question, we started with the transcripts for which riboHMM was able to 7 identify an mCDS and generated a set of "null transcripts" by permuting the footprint counts 8 among base positions within each transcript. Applying a posterior cutoff of 0.8, riboHMM 9 incorrectly identified an mCDS in 4.5% of these null transcripts. We used this estimate of 10 the Type 1 error rate to compute the false discovery rate for novel mCDS and uaCDS iden-11 tified by riboHMM. To address the second question, we started with the set of annotated 12 coding transcripts for which riboHMM was able to recover the precise CDS (i.e., the mCDS 13 matched the annotated CDS exactly). We generated a set of "simulated transcripts" using 14 the following strategy: (1) randomly select a new TIS downstream and in-frame to the an-15 notated TIS, ensuring that the codon underlying the new TIS belonged to the set ⌦ start , (2) 16 permute the footprint counts among bases upstream of the new TIS. Among the simulated 17 transcripts in which riboHMM could identify an mCDS, the inferred TIS matched the new 18 TIS exactly in 62% of transcripts; this corresponds to a false discovery proportion of 38%.
19
Translated mCDS in pseudogenes 1"
Starting with 14,065 pseudogenes that have been identified and categorized in humans 2" (Pei et al. 2012), 9,375 pseudogenes were identified by StringTie to be expressed in
3"
LCLs. Using a very stringent posterior cutoff of 99.99%, we inferred mCDS in 448 of
4"
these expressed pseudogenes. Using pairwise alignment of the pseudogene and parent
5"
gene transcript, we observed that although the pseudogene mCDS typically code for
6"
shorter protein sequences compared with the parent protein, a large fraction of the 7" pseudogene mCDS share coding-frame with their parent gene (see Figure S6A ).
8" 9"
Validation with Harringtonine-treated data 10"
Harringtonine-treated ribosome footprints were measured in LCLs with a total 11" sequencing depth of 21 million reads. In Figure 4 , we illustrate the aggregate proportion
12"
of treated ribosome footprints centered at the inferred start codon for all novel mCDS,
13"
and compare it with the aggregate proportion of treated footprints around the start codon
14"
of an equal number of annotated CDSs that have a posterior probability greater than 0.8
15"
under our model. In Figure S6B , we illustrate the aggregate proportion of treated
16"
footprints for mCDS inferred in pseudogenes alone, and in Figure 6B 
19"
20"
Identifying translated alternate ORFs 21"
For each transcript that had a mCDS with posterior greater than 0.8 and more than 50
22"
base pairs of RNA sequence in the 5'UTS state, we defined an "upstream-restricted
23"
transcript" consisting of the exons within the 5'UTS state. Using a random set of 5000
24"
non-overlapping upstream-restricted transcripts in which more than 80% of base 25" positions were mappable, we computed the maximum likelihood estimates of the
26"
transition parameters and occupancy parameters to identify additional translated
27"
sequences within these upstream-restricted transcripts. Assuming that the fine-scale
28"
structure of footprint counts within these translated sequences would be similar to that
29"
within the mCDS, we kept the periodicity parameters fixed to their previously estimated
30"
values. With these parameter estimates, we inferred the MAP frame and state
31"
sequences with posterior greater than 0.8 and filtered out inferences where less than
32"
50% of the inferred CDS was mappable. These additional translated sequences within
33"
the upstream-restricted transcripts were called upstream alternate coding sequences or 1" uaCDS.
2"
Identifying stable peptides with mass spectrometry data 4"
To identify stable proteins translated from the novel CDSs (mCDS and uaCDS), we
5"
analyzed quantitative, high-resolution mass spectrometry data derived from 60 LCLs,
6"
with MaxQuant v1.5.0.30 (Cox and Mann 2008) and the Andromeda (Cox et al. 2011) 7" search engine. Sample labeling, processing and data collection details can be found 8" elsewhere (Battle et al. 2015; Khan et al. 2013) . Peptides were identified using a 9" database that contained 63,904 GENCODE annotated protein sequences and 7,271
10"
novel CDSs identified by our method. For all searches, up to two missed tryptic 11" cleavages were allowed, carbamidomethylation of cysteine was entered as a fixed
12"
modification, and N-terminal acetylation and oxidation of methionine were included as
13"
variable modifications for all searches. A 'first search' tolerance of 40 ppm with a score
14"
threshold of 70 was used for time-dependent mass recalibration followed by a main
15"
search MS1 tolerance of 6 ppm and an MS2 tolerance of 20 ppm. The 're-quantify'
16"
option was used to aid the assignment of isotopic patterns to labeling pairs. The 'match 17" between runs' option was enabled to match identifications across samples using a
18"
matching time window of 42 seconds and an alignment time window of 20 min. Peptide
19"
and protein false discovery rates were set to 10% using a reverted version of the search
20"
database.
Protein group quantifications were taken as the median
21"
log ! (sample standard) ratio for all groups containing at least two independent unique or
22"
'razor' peptide quantifications (including multiple measurements of the same peptide in
23"
different fractions) without a modified peptide counterpart.
24"
25"
Bias correction to compute expected number of peptide hits 26"
Proteins with at least one peptide identified by this high-resolution mass-spectrometry
27"
protocol tend to be distinct from proteins with no mass-spectrum matches.
28"
1. The median footprint density of annotated coding genes with at least one peptide
29"
match is about 125 fold higher than that of coding genes with no peptide match (see
30"
Figure S12A).
31"
2. The median length of coding genes with at least one peptide match is 20% higher 32" than that of coding genes without a peptide match (see Figure S12B ).
33"
3. The trypsin cleavage step of the protocol ensures that nearly all observable peptides
1"
have a C-terminal lysine or arginine residue, and up to two additional lysine or 2" arginine residues within the peptide sequence (called "tryptic peptides"). This step
3"
imposes a strict constraint on the set of unique peptide sequences that can be 4" observed from a protein sequence, and genes with fewer tryptic peptides are less 5" likely to have a mass-spectrum match.
6"
4. All tryptic peptides in an expressed protein are not equally likely to be observed. The
7"
probability of detecting a tryptic peptide depends on its electrostatic properties 8" relative to other tryptic peptides from all expressed proteins, which in turn depends
9"
on the amino acid composition of the tryptic peptides (see Figure S12 C-F).
10"
11"
To account for these biases, we developed a predictive model to estimate the probability
12"
that a protein has at least one peptide hit in a mass-spectrometry experiment. The
13"
predicted label for a protein is whether the protein has at least one mass-spectrum
14"
match (! ! = 1) or no mass-spectrum match (! ! = 0). The predictive features of a
15"
protein used in the model are (1) the ribosome footprint density of the corresponding
16"
transcript (! ! ), (2) the protein length (! ! ), and (3) the counts of amino acids within each
17"
of the ! tryptic peptides that can be generated from the protein (! ! = ! !! , ⋯ , ! !" ).
18"
Since the relevant feature of an amino acid is its charge, we partitioned the set of amino
19"
acids into four groups -positively charged (R, H, K), negatively charged (D, E), polar 20" uncharged (S, T, N Q), and others. The amino acid count vector ! !" was then collapsed
21"
into a vector of the counts of each of these four groups. Conditional on ! ! = 1, we
22"
introduced a latent variable for each tryptic peptide that indicates whether the peptide
23"
was matched to a mass-spectrum or not (! !" ∈ 1,0 ); this latent variable accounts for
24"
differences between matched and unmatched peptides.
25"
26"
Assuming that the three predictive features are independent conditional on the predicted
27"
label ! ! , the odds of observing at least one peptide hit is then given as
28"
29"
30"
We learn the predictive model using annotated coding genes and partitioning them into 1"
those that have at least one peptide hit ("hit genes") and those that do not have a 2" peptide hit ("no-hit genes"). We computed !(! ! |! ! ) using an empirical distribution of
3"
footprint density within coding genes, !(! ! |! ! ) using an empirical distribution of the
4"
lengths of coding genes, ! ! !" ! !" = 1, ! ! = 1 using tryptic peptides within hit genes
5"
matched to mass-spectra, ! ! !" ! !" = 0, ! ! = 1 using unmatched tryptic peptides
6"
within hit genes, and ! ! !" ! !" = 0, ! ! = 0 using tryptic peptides within no-hit genes.
7"
Finally, we set ! ! ! = 1 = ! ! ! = 0 = 1 2 and ! ! ! ! ! = 1 = 1 (2 ! − 1) . Using
8"
peptide hits in annotated proteins, we evaluated the accuracy of this model by holding
9"
out some annotated proteins as test data, learning the predictive distributions using the
10"
remaining training data and computing the expected number of test proteins that had a
11"
mass-spectrum match. We estimated the expected number of held-out annotated
12"
proteins with at least one mass-spectrum match to be 1,206 (s.d.=34), while the actual
13"
number of held-out proteins with a match was 1,387 (s.d.=36).
14"
15"
Test for long-term purifying selection 16"
In order to quantify whether the novel mCDS are evolutionary conserved in terms of their
17"
amino acid sequence, we first extracted DNA sequences orthologous to the mCDS from 18" a 100-way vertebrate whole-genome alignments (UCSC), restricting to genomes aligned
19"
with either Syntenic net or Reciprocal best net. We next performed a 3-frame translation 20" on each orthologous sequence and a multiple alignment to obtain the correct codon
21"
alignments. More specifically, for each orthologous sequence, we kept the frame with
22"
the highest amino acid identity compared to the human peptide, requiring at least 60%
23"
identity for alignable positions and no more than 50% of the alignment as gaps. Finally,
24"
we used codeML/PAML (Yang 2007) to estimate dN and dS rates across the trees
25"
consisting of all remaining peptides, first using a model allowing variable omega and 26" then a model with omega fixed to one. To determine whether a specific peptide is under
27"
purifying selection or not, we compared the two models using a likelihood ratio test and
28"
reported peptides that satisfied a Bonferroni-corrected p-value threshold.
29"
30"
Correlation between uaCDS and mCDS 31"
We computed the correlation across LCLs between the proportion of footprints mapped
32"
to a transcript that fall within its uaCDS and the proportion that fall within its mCDS. We
33"
evaluated the statistical significance of these correlations using an empirical null 34" distribution of Spearman correlations computed using random pairs of mCDS and 1" uaCDS. A random pair of mCDS and uaCDS was obtained by randomly shifting the
2"
coordinates of an observed pair of mCDS and uaCDS, matching for their respective 3" lengths and the distance between them.
4"
5"
Data Release
6"
All novel coding sequences identified in this work, along with the harringtonine-treated
7"
ribosome profiling data are deposited in GEO Accession GSE75290.
8"
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4"
for 29 bp long footprints, estimated using the top 5000 expressed genes. Each red circle indicates the
5"
parameter values estimated by using a random set of 1000 genes. estimates of the occupancy parameters in each state, ! ! (scaled by ! TES for mCDS). For mCDS (dark gray),
10"
the parameters were estimated using the top 5000 expressed genes, and the red circles indicate parameter
11"
values estimated using a random set of 1000 genes. For uaCDS (light gray), the parameters were estimated 12" using a random set of 5000 upstream-restricted transcripts, and each red circle indicates values estimated
13"
using random sets of 1000 upstream-restricted transcripts.
14" 15"
" 1" Figure S3 : Decision rules to identify matches and mismatches of mCDS to annotation. Illustrating the
2"
decisions by which mCDS inferred on each transcript are identified as an exact match, a frame match) or a 3" mismatch to annotated coding sequences. Matches and mismatches are only defined when the transcript is
4"
annotated by GENCODE as coding and the classification depends on agreement with the annotated CDS. A
5"
gene is considered to have an exact (or frame) match if at least one of its isoforms is labeled an exact (or 6" frame) match. In all other cases, the inference for the coding gene is considered a mismatch. 
10"
CDSs accurately recovered as a function of total footprint sequencing depth. We performed the entire 11" analysis on the same set of assembled transcripts (parameter estimation and inference) after subsampling 12" the data. Starting with inferences using the complete footprint data set that exactly match annotated CDSs
13"
(top subpanel), we show the fraction of these CDSs that were accurately (blue) and inaccurately (brown)
14"
recovered with a high posterior for varying sequencing depths. Starting with inferences that only match the
15"
frame of annotated CDSs (bottom subpanel), we show the fraction of accurately and inaccurately recovered
16"
CDSs for varying sequencing depths. 
17"
2"
The mCDS that do not overlap any known CDS (pooling GENCODE, UCSC and CCDS annotations) are
3"
labeled as novel mCDS --these include mCDS from both novel and annotated transcripts.! harringtonine-arrested ribosome occupancy at the inferred translation initiation sites validates our inferred 8" mCDS in pseudogenes. (C) Nonsynonymous variants (orange) segregate at significantly lower frequencies 9" than synonymous variants (blue) in those pseudogenes predicted to have a translated CDS. Pseudogenes
4"
10"
with ribosome occupancy, but predicted to have no translated CDS, do not show any significant difference
11"
between the site frequency spectra of synonymous and nonsynonymous variants. 
5"
expressed genes, it is reasonable to assume that the expected footprint count in a triplet scales linearly with
6"
RNA-seq density. However, for lowly expressed genes and outlier genes (i.e., genes with high expected 7" footprint count and low RNA-seq density, and genes with high RNA-seq density and low expected footprint 8" count), this assumption may not be valid. 
3"
unique peptide hit (blue) and genes with no unique peptide hit (red). The median footprint density of genes
4"
with a peptide hit is about 125 fold higher than the median footprint density of genes without a peptide hit.
5"
(B) Cumulative distribution of protein length for genes with at least one unique peptide hit (blue) and genes
6"
with no unique peptide hit (red). Genes with a peptide hit tend to code for proteins that are 20% longer than 7" proteins encoded by genes without a peptide hit. (C-F) Comparing amino acid composition within tryptic
8"
peptides with a mass-spectrum match and tryptic peptides without a mass-spectrum match. Amino acids,
9"
grouped by their electrostatic properties, have distinct compositions between matched and unmatched 10" peptides. Matched peptides tend to be significantly shorter than unmatched peptides, and have a distinct
11"
composition of charged amino acids.!
12"
